Long-term evolution and predictive factors of mild inflammatory bowel disease

被引:11
|
作者
Reenaers, C. [1 ]
Pirard, C. [1 ]
Vankemseke, C. [1 ]
Latour, P. [1 ]
Belaiche, J. [1 ]
Louis, E. [1 ]
机构
[1] Univ Hosp Liege, Dept Gastroenterol, Liege, Belgium
关键词
Benign evolution; mild IBD; complication; predictive factor; CROHNS-DISEASE; ULCERATIVE-COLITIS; COLORECTAL-CANCER; CLINICAL-COURSE; RISK; CLASSIFICATION; INFECTIONS; MORTALITY; COLECTOMY; BEHAVIOR;
D O I
10.3109/00365521.2015.1128965
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Crohn's disease (CD) and ulcerative colitis (UC) are potentially progressive diseases. Few data are available on the prevalence and the factors associated with mild inflammatory bowel diseases (IBD). Aim Our aim was to assess the natural history of mild CD and mild UC and to identify predictive factors of mild evolution over the long term. Methods Retrospective study of IBD patients registered in the database of the university hospital CHU of Liege, Belgium. Mild CD was defined as an inflammatory luminal disease (no stricture, abdominal or perianal fistulae) requiring no immunomodulator (IM), anti-TNF and no surgery. Mild UC was defined as no requirement for IM, anti-TNF and no colectomy. Results Four hundred and seventy-three CD and 189 UC were included (median follow-up: 13 and 11 years respectively). At 1 year, 147 patients had mild CD. At 5 years and the maximum follow-up, 56% and 13% patients still had mild CD, respectively. At 1 year, 142 patients had mild UC. At 5 years and the maximum follow-up, 72% and 44% still had a mild UC, respectively. Factors associated with long-term mild CD and UC were older age at diagnosis and absence of corticosteroids in the first year. In UC proctitis location was associated with mild UC. Conclusions In this cohort, 90% of CD patients and 3/4 of UC with mild disease at 1 year lost their mild disease status over time. An old age at diagnosis was predictive of the persistence of a mild CD and UC.
引用
收藏
页码:712 / 719
页数:8
相关论文
共 50 条
  • [41] EARLY AND LONG-TERM OUTCOME OF SURGICAL INTERVENTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Khosravi, Farbod
    Ziaeefar, Pardis
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2020, 33 (02):
  • [42] Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
    Wyant, Timothy
    Yang, Lili
    Lirio, Richard A.
    Rosario, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1174 - 1181
  • [43] Will sustained biological therapy improve long-term outcome in inflammatory bowel disease?
    Myrelid, Par
    Eberhardson, Michael
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (7-8):
  • [44] Long-term efficacy of 6-thioguanine in patients with inflammatory bowel disease
    Teml, A
    Dejaco, C
    Miehsler, W
    Harrer, M
    Vogelsang, H
    Reinisch, W
    GASTROENTEROLOGY, 2005, 128 (04) : A587 - A587
  • [45] LONG-TERM MONITORING OF PSYCHOSOCIAL STRESS AND SYMPTOMATOLOGY IN INFLAMMATORY BOWEL-DISEASE
    GREENE, BR
    BLANCHARD, EB
    WAN, CK
    BEHAVIOUR RESEARCH AND THERAPY, 1994, 32 (02) : 217 - 226
  • [46] Long-Term Safety of Infliximab in CVID-Related Inflammatory Bowel Disease
    Verma, N.
    Webster, A. D.
    Seneviratne, S. L.
    Burns, S. O.
    Dziadio, M.
    Symes, A.
    Workman, S.
    Grimbacher, B.
    Chee, R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S166 - S167
  • [47] Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
    Fraser, AG
    Orchard, TR
    Robinson, EM
    Jewell, DP
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) : 1225 - 1232
  • [48] Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
    Martinez Ibeas, M. A.
    Bacelo Ruano, I.
    Rodriguez Manchon, S.
    Velasco Rodriguez-Belvis, M.
    Viada Bris, J. F.
    Dominguez Ortega, G.
    Munoz Codoceo, R. A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S573 - S573
  • [49] Long-term Motor and Cognitive Function in the Children of Women With Inflammatory Bowel Disease
    Friedman, Sonia
    Nielsen, Jan
    Jolving, Line Riis
    Nohr, Ellen A.
    Norgard, Bente Mertz
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (12): : 1709 - 1716
  • [50] Long-term treatment of inflammatory bowel disease associated spondyloarthropathy with infliximab.
    Antivalle, Marco
    Mutti, Alessandra
    Bertani, Luca
    Randisi, Giovanna
    Vulpio, Laura
    Ardizzone, Sandro
    Colombo, Elisabetta
    Carrabba, Mario
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S472 - S472